NAUT Stock Performance ; Previous close, ; Day range, - ; Year range, 2 - 4 ; Market cap, ,, ; Primary exchange, NASDAQ. On Friday 08/30/ the closing price of the Nautilus Biotechnology Inc Registered Shs share was $ on BTT. Compared to the opening price on Friday 08/30/. View the NAUT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nautilus Biotechnology. After Hours: $ (%) ; Coherus Biosciences Inc. $ CHRS % ; bluebird bio Inc. $ BLUE % ; Cabaletta Bio Inc. $ CABA % ; Ocular. Nautilus Biotechnology, Inc. (NAUT) ; Aug 12, , , , , ; Aug 9, , , , ,
Get the Live stock price of Nautilus Biotechnology Inc (NAUT), Check its Financials, Fundamental Data, Overview, Technicals, Returns & Earnings over the. Is Nautilus Biotechnology, Inc. stock A Buy? Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current. NAUT | Complete Nautilus Biotechnology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Nautilus Biotechnology Inc ; Jun, Initiated, Guggenheim, Buy, $6 ; Jun, Resumed, Jefferies, Hold, $3. Nautilus Biotechnology, Inc. (resana.site): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Nautilus Biotechnology. Nautilus Biotechnology, Inc. is currently listed on NASDAQ under NAUT. One share of NAUT stock can currently be purchased for approximately $ Key Stats · Market CapM · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and. Nautilus Biotechnology, Inc. is a life sciences company, which engages in the development of a proteomics platform for analyzing and quantifying the human. Nautilus became a publicly traded company on June 10, as a result of the combination of Nautilus Biotechnology, Inc. with ARYA Life Sciences Acquisition. Stock analysis for Nautilus Biotechnology Inc (NAUT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company.
14, (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform. Find the latest Nautilus Biotechnology, Inc. (NAUT) stock quote, history Nautilus Biotechnology, Inc. (NAUT). Follow. Compare. + (+ Learn how the Nautilus Platform is designed to performed in-depth, single-molecule analysis of proteoforms. The last closing price for Nautilus Biotechnology was $ Over the last year, Nautilus Biotechnology shares have traded in a share price range of $ to $. Nautilus Biotechnology Inc. ; 12 Month Change. % ; Day Range - ; 52 Wk Range - ; Volume, K ; Market Value, $M. Nautilus Biotechnology Inc. ; Prev. Close. ; Low. ; 52wk Low. ; Market Cap. m ; Total Shares. m. Discover real-time Nautilus Biotechnolgy, Inc. Common Stock (NAUT) stock prices, quotes, historical data, news, and Insights for informed trading and. Nautilus Biotechnology NasdaqGS:NAUT Stock Report ; Last Price. US$ ; Market Cap. US$m ; 7D. % ; 1Y. % ; Updated. 03 Sep, Company Profile. Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the.
Nautilus Biotechnology Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Nautilus Biotechnology Inc.'s. Nautilus Biotechnology seeks to transform the field of proteomics by Stock Information. NASDAQ GS: NAUT. Price. $ Change. (%). Volume. Nautilus Biotechnology (NASDAQ:NAUT) Stock Quotes, Forecast and News Summary ; Day Range, - - - ; 52 Wk Range, - ; Market Cap, $M ; P/E Ratio, -. As of Aug the stock price of Nautilus Biotechnology is $ What is the current market cap of Nautilus Biotechnology? The current market. NAUT Stock Performance ; Previous close, ; Day range, - ; Year range, 2 - 4 ; Market cap, ,, ; Primary exchange, NASDAQ.
Nautilus Biotechnology to Announce Second Quarter Financial Results on July 30, Globe Newswire (Tue, 9-Jul AM ET). Nautilus Biotechnology, Inc. (NasdaqGS:NAUT) institutional ownership structure shows current positions in the company by institutions and funds, as well as. Track Nautilus Biotechnology Inc (NAUT) Stock Price, Quote, latest community messages, chart, news and other stock related information.
Nautilus Biotechnology